These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33781760)

  • 1. Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois.
    Rasmussen KN; Janiak E; Cottrill AA; Stulberg DB
    Contraception; 2021 Jul; 104(1):98-103. PubMed ID: 33781760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics✰,✰✰.
    Razon N; Wulf S; Perez C; McNeil S; Maldonado L; Fields AB; Carvajal D; Logan R; Dehlendorf C
    Contraception; 2022 May; 109():19-24. PubMed ID: 35131289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstetrician-gynecologist willingness to provide medication abortion with removal of the in-person dispensing requirement for mifepristone.
    Daniel S; Schulkin J; Grossman D
    Contraception; 2021 Jul; 104(1):73-76. PubMed ID: 33811840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States.
    Koenig LR; Raymond EG; Gold M; Boraas CM; Kaneshiro B; Winikoff B; Coplon L; Upadhyay UD
    Contraception; 2023 May; 121():109962. PubMed ID: 36736715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to abortion provision in primary care in New England, 2019-2020: A qualitative study.
    Lee CM; Johns SL; Stulberg DB; Allen RH; Janiak E
    Contraception; 2023 Jan; 117():39-44. PubMed ID: 35970423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary care and abortion provider perspectives on mail-order medication abortion: a qualitative study.
    Raifman S; Gurazada T; Beaman J; Biggs MA; Schwarz EB; Gold M; Grossman D
    BMC Womens Health; 2024 Jul; 24(1):382. PubMed ID: 38956609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care.
    Srinivasulu S; Yavari R; Brubaker L; Riker L; Prine L; Rubin SE
    Contraception; 2021 Jul; 104(1):92-97. PubMed ID: 33910031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment.
    Grossman D; Raifman S; Morris N; Arena A; Bachrach L; Beaman J; Biggs MA; Hannum C; Ho S; Schwarz EB; Gold M
    Contraception; 2022 Mar; 107():36-41. PubMed ID: 34555420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication abortion: Potential for improved patient access through pharmacies.
    Raifman S; Orlando M; Rafie S; Grossman D
    J Am Pharm Assoc (2003); 2018; 58(4):377-381. PubMed ID: 29752204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "No Big Deal": A Qualitative Study of Pharmacists' Perspectives on Dispensing Mifepristone for Medication Abortion.
    Kaller S; Ma M; Gurazada T; Baba CF; Rafie S; Raine-Bennett T; Averbach S; Chen M; Berry E; Meckstroth KR; Grossman D
    Womens Health Issues; 2022; 32(6):571-577. PubMed ID: 35918240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States.
    Calloway D; Stulberg DB; Janiak E
    Contraception; 2021 Jul; 104(1):24-28. PubMed ID: 33891965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists' knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion.
    Kaller S; Morris N; Biggs MA; Baba CF; Rafie S; Raine-Bennett TR; Creinin MD; Berry E; Micks EA; Meckstroth KR; Averbach S; Grossman D
    J Am Pharm Assoc (2003); 2021; 61(6):785-794.e1. PubMed ID: 34281806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacy Provision of Medication Abortion in Nepal: Pharmacy Owner and Worker Perspectives.
    Samari G; Puri M; Cohen R; Blum M; Rocca CH
    Int Perspect Sex Reprod Health; 2018 Sep; 44(3):81-89. PubMed ID: 30698524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person Screening.
    Grossman D; Raifman S; Morris N; Arena A; Bachrach L; Beaman J; Biggs MA; Collins A; Hannum C; Ho S; Seibold-Simpson SM; Sobota M; Tocce K; Schwarz EB; Gold M
    JAMA Intern Med; 2024 May; ():. PubMed ID: 38739404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of early medication abortion provided in pharmacies by auxiliary nurse-midwives: A non-inferiority study in Nepal.
    Rocca CH; Puri M; Shrestha P; Blum M; Maharjan D; Grossman D; Regmi K; Darney PD; Harper CC
    PLoS One; 2018; 13(1):e0191174. PubMed ID: 29351313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone implementation in primary care: Clinician and staff insights from a pilot learning collaborative.
    Sakthivel M; Wolff H; Monast K; McHugh A; Stulberg D; Janiak E
    Contraception; 2024 Feb; 130():110280. PubMed ID: 37704043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "We've got rights and yet we don't have access": Exploring patient experiences accessing medication abortion in Australia.
    LaRoche KJ; Wynn LL; Foster AM
    Contraception; 2020 Apr; 101(4):256-260. PubMed ID: 31927029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Federal, state, and institutional barriers to the expansion of medication and telemedicine abortion services in Ohio, Kentucky, and West Virginia during the COVID-19 pandemic.
    Mello K; Smith MH; Hill BJ; Chakraborty P; Rivlin K; Bessett D; Norris AH; McGowan ML
    Contraception; 2021 Jul; 104(1):111-116. PubMed ID: 33930382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "It was close enough, but it wasn't close enough": A qualitative exploration of the impact of direct-to-patient telemedicine abortion on access to abortion care.
    Kerestes C; Delafield R; Elia J; Chong E; Kaneshiro B; Soon R
    Contraception; 2021 Jul; 104(1):67-72. PubMed ID: 33933421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project.
    LaRoche KJ; Wylie A; Persaud M; Foster AM
    Contraception; 2022 May; 109():37-42. PubMed ID: 35031301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.